resveratrol has been researched along with amiloride in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Alzamora, R; Edinger, RS; Fischer, O; Hallows, KR; Johnson, JP; Li, H; Marciszyn, A; Weixel, KM | 1 |
Gündoğdu, AÇ; Özyurt, R | 1 |
3 other study(ies) available for resveratrol and amiloride
Article | Year |
---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Resveratrol inhibits the epithelial sodium channel via phopshoinositides and AMP-activated protein kinase in kidney collecting duct cells.
Topics: Amiloride; AMP-Activated Protein Kinases; Animals; Cell Line; Cells, Cultured; Epithelial Sodium Channels; Immunoblotting; Kidney Tubules, Collecting; Mice; Phosphatidylinositols; Resveratrol; RNA, Small Interfering; Stilbenes | 2013 |
Resveratrol downregulates ENaCs through the activation of AMPK in human colon cancer cells.
Topics: Amiloride; AMP-Activated Protein Kinases; Apoptosis; Colonic Neoplasms; Epithelial Sodium Channels; Humans; Resveratrol | 2023 |